Stryker to buy Entellus Medical for $662 mln

Shutterstock photo

Dec 7 (Reuters) - Medical device maker Stryker Corp said on Thursday it would buy medical technology company Entellus Medical Inc in a deal valued at about $662 million, adding heft to its ENT business.

Stryker would pay $24 per Entellus share, a premium of about 50 percent to Entellus's Wednesday close.

The deal to expected to be dilutive to Stryker's 2018 adjusted net earnings per share by about 4 cents, but accretive thereafter, the company said.

This article appears in: World Markets , Stocks
Referenced Symbols: ENTL ,

More from Reuters


See headlines for ENTL

Research Brokers before you trade

Want to trade FX?